Skip to main content
SpringerLink
Log in

Safe use of zolpidem is uncommon in the US

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The lower recommended zolpidem dose was 5 mg/day for immediate-release zolpidem products and 6.25 mg/day for extended-release products.

Reference

  • Moore TJ, et al. Assessment of Patterns of Potentially Unsafe Use of Zolpidem. JAMA Internal Medicine : [2 pages], 16 Jul 2018. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2018.3031

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safe use of zolpidem is uncommon in the US. Reactions Weekly 1713, 13 (2018). https://doi.org/10.1007/s40278-018-49847-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-49847-8

Search

Navigation